(Reuters) - Questcor Pharmaceuticals Inc said it is now eligible to provide lower Medicaid rebates on its flagship multiple sclerosis drug, Acthar Gel, allowing for improved financial results in the future.
via Reuters: Health News Read More Here..
No comments:
Post a Comment